This study examines the Chinese pharmaceuticals market – a sector that has steadily posted solid and swift growth at an annual clip exceeding 20% in recent years.

1. China Already a Top Market

• As of 2012, the Chinese pharmaceuticals market was No. 3 in the world. By 2020, it is expected to rise to No. 2.
• The Chinese market in these products offers higher profitability than its counterparts in developed nations.

2. Shifting from “Sales-Driven Marketing” to “Market Access”

• The end of the era of sales supported by quantitative superiority and sheer sales strength.
• Meticulous market access to regional governments holds the key to success from here on.

3. Demands for Precision Market Grasp

• Sizing up markets through local products.
• Spot-on assessment of business opportunities.